January 2007

Key figure in Libby situation dies of mesothelioma

The Washington Post reports (via the Los Angeles Times) the passing of Les Skramstad, one of the early leaders notifying the world about the dangers from the Libby Montana vermiculite mine. Skramstad worked there from 1959 to 1962 and was diagnosed with asbestosis in 1996. He subsequently got mesothelioma, which is what he died from. …

Key figure in Libby situation dies of mesothelioma Read More »

M.D. Anderson reports success with kinase inhibitors

Not direct mesothelioma news, but interesting and encouraging nevertheless. Scientists at M.D. Anderson had success with MK-0457 (VX-680), a novel multi-kinase inhibitor, to treat leukemia and myeloproliferative disorders. Kinase inhibitors are one of the most promising areas of research in cancer treatment today.

Trends in cancer incidence

Ogan Gurel has an article on the Wisconsin Technology Network website about the recent decline in cancer deaths in the United States. He identifies the four major technical advances in cancer therapy in the past decade. Earlier detection and diagnosis. Targeted therapies. Personalized medicine. Minimally invasive surgery.